Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer
Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 others, 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus) -
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T. F. J., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P., Koster, J., Zwijnenburg, D. A., Spek, C. A., Klomp, J. P. G., Oubrie, A., Hooijer, G. K. J., Meijer, S. L., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J., Oyarce, C., Medema, J. P., & 2 others, 15 Nov 2022, In: Cell Reports Medicine. 3, 11, 100802.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus) -
Molecular characterization of colorectal cancer related peritoneal metastatic disease
Lenos, K. J., Bach, S., Ferreira Moreno, L., ten Hoorn, S., Sluiter, N. R., Bootsma, S., Vieira Braga, F. A., Nijman, L. E., van den Bosch, T., Miedema, D. M., van Dijk, E., Ylstra, B., Kulicke, R., Davis, F. P., Stransky, N., Smolen, G. A., Coebergh van den Braak, R. R. J., IJzermans, J. N. M., Martens, J. W. M., Hallam, S., & 20 others, 1 Dec 2022, In: Nature communications. 13, 1, 4443.Research output: Contribution to journal › Article › Academic › peer-review
Open Access12 Citations (Scopus) -
Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm phase ii feasibility trial (PERFECT)
Van Den Ende, T., De Clercq, N. C., Van Berge Henegouwen, M. I., Gisbertz, S. S., Geijsen, E. D., Verhoeven, R. H. A., Meijer, S. L., Schokker, S., Dings, M. P. G., Bergman, J. J. G. H. M., Mohammad, N. H., Ruurda, J. P., Van Hillegersberg, R., Mook, S., Nieuwdorp, M., De Gruijl, T. D., Soeratram, T. T. D., Ylstra, B., Van Grieken, N. C. T., Bijlsma, M. F., & 2 others, Jun 2021, In: Clinical Cancer Research. 27, 12, p. 3351-3359 9 p.Research output: Contribution to journal › Article › Academic › peer-review
88 Citations (Scopus) -
Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer
Dings, M. P. G., Vermeulen, L. & Bijlsma, M. F., 1 Jan 2021, Research and Clinical Applications of Targeting Gastric Neoplasms. Elsevier, p. 259-288 (Research and Clinical Applications of Targeting Gastric Neoplasms).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
Prizes
-
CCA Preclinical Impact Award 2022
Dings, Mark (Recipient), 7 Jul 2023
Prize: Other prizes and awards › Academic
-
Activities
- 1 Invited talk
-
Towards a peritoneal MetMap
Mark Dings (Speaker)
8 Jun 2023Activity: Talk or presentation › Invited talk › Academic